NCBiotech News

Winston-Salem's EncepHeal Therapeutics has landed a federal grant to support development of its novel medications for cocaine addiction.

Less than two years after launching, Avior Bio is kicking off its first human trial for a novel drug therapy treating pruritus, or chronic itchy skin

RTP-based Panaceutics Nutrition has launched I-Vive, a new line of single-serve nutritional products compounded for the general public

North Carolina’s global leadership in biomanufacturing has drawn another spotlight with a White House announcement that President Donald Trump will be visiting the Triangle on Monday, July 27, to a company involved in producing COVID-19 vaccine.

Boragen, Inc., a boron-based discovery platform company based in RTP, has won a $300,500 Phase I Small Business Innovation Research grant for research on controlling malaria.

Winston-Salem's KeraNetics has received FDA approval for its KeraStat Cream to treat debilitating skin burns from radiation therapy.

Chapel Hill's Path BioAnalytics has joined forces with Australian researchers to study a new drug to fight COVID-19

This month’s NC Biotech Jobs Network featured a panel of three consulting experts who discussed their experiences in starting their own consulting businesses. Panelists included James Iademarco, Principal, Strategic Avalanche LLC; Nannette (Net) Stangle-Castor, Ph.D., President and Founder, InnoVector Tech Inc.; and Scott Rockafellow, President, Granite Beach Management. Each panelist gave a short slide presentation and provided complementary lessons on what is required to become a consultant.